Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer.
J Immunother Cancer. 2019 Sep 18;7(1):252. doi: 10.1186/s40425-019-0728-4.
J Immunother Cancer. 2019.
PMID: 31533840
Free PMC article.